Insulin drops for faster healing after corneal crosslinking
Treatments studied
Part of Eyes & vision clinical trials.
This trial tests whether insulin eye drops can help the cornea heal faster after corneal crosslinking, a procedure to treat keratoconus. It is for people with keratoconus who do not have diabetes, severe dry eye, or certain other eye conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have keratoconus and are planning to have corneal crosslinking (a procedure to strengthen your cornea).
- You do not have diabetes.
- You do not have severe dry eye.
- You do not have limbal stem cell deficiency (a condition that affects the eye's surface healing).
- You do not have glaucoma.
- You are not allergic to insulin or methylcellulose (a common eye drop ingredient).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to manage inflammation after corneal crosslinking for keratoconus: a tiny steroid insert placed in the tear duct versus standard steroid eye drops. It aims to see which option is easier and works just as well.
This study tests a same-day procedure that strengthens the cornea (the clear front part of the eye) in both eyes using a special light treatment, called cross-linking. It may help slow or stop the progression of keratoconus, a condition where the cornea becomes cone-shaped and causes blurry vision.
This study tests whether treating donor corneal tissue with a special light and vitamin drops (called cross-linking) before a transplant helps improve outcomes for people with keratoconus. If you need a corneal transplant, this could strengthen the donor tissue and potentially reduce the need for future procedures.
This study tests a procedure called corneal crosslinking to slow or stop the progression of keratoconus or corneal ectasia. It might help keep your cornea stable and prevent further vision loss.
This trial studies collagen cross-linking, a procedure meant to strengthen a weakened cornea in people with keratoconus. It may help slow the bulging/weakening of the cornea and improve vision, and the study also uses special imaging to check changes over time.
This study measures eye pressure before and after a treatment called corneal cross-linking for a condition called keratoconus, which thins and bulges the cornea. It aims to see if the treatment affects eye pressure, which can help manage the condition better.
Hear when a new Keratoconus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.